Nevro Corp

General ticker "NVRO" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $261.7M (TTM average)

Nevro Corp does not follow the US Stock Market performance with the rate: -28.8%.

Estimated limits based on current volatility of 0.2%: low 5.84$, high 5.86$

Factors to consider:

  • US accounted for 86.4% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [2.06$, 6.55$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.44$, 7.01$]

Financial Metrics affecting the NVRO estimates:

  • Negative: Non-GAAP EPS, $ of -2.28 <= 0.04
  • Negative: negative Operating income
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -11.25 <= 1.81

Similar symbols

Short-term NVRO quotes

Long-term NVRO plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $406.37MM $425.17MM $408.52MM
Operating Expenses $505.20MM $524.48MM $534.75MM
Operating Income $-98.84MM $-99.31MM $-126.23MM
Non-Operating Income $103.10MM $1.45MM $13.88MM
Interest Expense $6.43MM $8.01MM $26.89MM
R&D Expense $53.06MM $54.42MM $51.51MM
Income(Loss) $4.26MM $-97.86MM $-112.35MM
Taxes $1.26MM $-5.65MM $1.09MM
Profit(Loss)* $3.00MM $-92.21MM $-113.44MM
Stockholders Equity $323.88MM $293.14MM $231.01MM
Inventory $99.64MM $118.68MM $103.27MM
Assets $602.41MM $635.71MM $553.84MM
Operating Cash Flow $24.68MM $-58.83MM $-19.44MM
Capital expenditure $7.54MM $8.59MM $9.79MM
Investing Cash Flow $64.29MM $-7.20MM $14.63MM
Financing Cash Flow $-2.46MM $49.53MM $-4.21MM
Earnings Per Share** $0.08 $-2.56 $-3.06

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.